compound introduction
Information VK-II-36 is a carvedilol analog that suppresses sarcoplasmic reticulum (SR) Ca(2+) release but does not block the β-receptor.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
VK-II-36
Dangerous GoodsCAS number：955371-66-1 molecular formula：C26H26N2O5
overview
Specs
| Chinese alias | - | ||
| English alias | 6-[(9H-Carbazol-4-yloxy)methyl]-4-[2-(2-methoxyphenoxy)ethyl]-3-morpholinone | NCGC00370679-02 | VK-II-36 | 6-(9H-carbazol-4-yloxymethyl)-4-[2-(2-methoxyphenoxy)ethyl]morpholin-3-one | NCGC00370679-04 | NCGC00370679-03 | EX-A4713 | 6-[(9H-CARBAZOL-4-YLOXY | ||
| CAS number | 955371-66-1 | molecular formula | C26H26N2O5 |
| molecular weight | 446.5 g/mol | Exact mass | ≥98% |
| PSA | 73.000 Ų | logp | 4.500 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
pictogram：
GHS07
Signal word：
Warning
Hazard Statement：
H302: 吞食有害
Statement of Preventive Measures：
P501: 将内容物/容器处理到。。。 P264: 处理后要彻底洗手。 P270: 使用本产品时，请勿进食、饮水或吸烟。 P330: 漱口 P301+P317: 如果被吞咽：请寻求医疗帮助。
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
